Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Obesity

  Free Subscription


Articles published in Eur J Endocrinol

Retrieve available abstracts of 68 articles:
HTML format



Single Articles


    May 2021
  1. GROOTJEN LN, Rutges JPHJ, Damen L, Donze SH, et al
    Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2021;185:47-55.
    PubMed     Abstract available


  2. DAMEN L, Grootjen LN, Donze SH, de Graaff LCG, et al
    Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
    Eur J Endocrinol. 2021;184:773-782.
    PubMed     Abstract available


  3. MCNEILL BT, Suchacki KJ, Stimson RH
    MECHANISMS IN ENDOCRINOLOGY: Human brown adipose tissue as a therapeutic target: warming up or cooling down?
    Eur J Endocrinol. 2021;184:R243-R259.
    PubMed     Abstract available


  4. SUBRAMANIAN A, Anand A, Adderley NJ, Okoth K, et al
    Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
    Eur J Endocrinol. 2021;184:637-645.
    PubMed     Abstract available


  5. DE ZEGHER F, Ibanez L
    On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls.
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0287. doi: 10.1530/EJE-21-0287.
    PubMed     Abstract available


  6. LEGER J, Delcour C, De Roux N, Carel JC, et al
    Response to letter to the editor (from De Zegher and Ibanes) (On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls).
    Eur J Endocrinol. 2021 May 1. pii: EJE-21-0445. doi: 10.1530/EJE-21-0445.
    PubMed     Abstract available


    April 2021
  7. REYES M, Gonzalez L, Ibeas K, Cereijo R, et al
    White adipose tissue-infiltrated CD11b+ myeloid cells are a source of S100A4, a new potential marker of hepatic damage.
    Eur J Endocrinol. 2021;184:533-541.
    PubMed     Abstract available


  8. JUN JE, Kang M, Jin SM, Kim K, et al
    Additive effect of low skeletal muscle mass and abdominal obesity on coronary artery calcification.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-20-0885.R1. doi: 10.1530/EJE-20-0885.
    PubMed     Abstract available


  9. STENSEN S, Gasbjerg LS, Krogh LL, Skov-Jeppesen K, et al
    Effects of endogenous GIP in patients with type 2 diabetes.
    Eur J Endocrinol. 2021 Apr 1. pii: EJE-21-0135.R1. doi: 10.1530/EJE-21-0135.
    PubMed     Abstract available


    January 2021
  10. VALDES N, Tirosh A, Keil M, Stratakis CA, et al
    Pediatric Cushing's syndrome: greater risk of being overweight or obese after long-term remission and its predictive factors.
    Eur J Endocrinol. 2021;184:179-187.
    PubMed     Abstract available


    December 2020
  11. LAPAUW B, Kaufman JM
    MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
    Eur J Endocrinol. 2020;183:R167-R183.
    PubMed     Abstract available


    November 2020
  12. BEAVERS KM, Greene KA, Yu EW
    MANAGEMENT OF ENDOCRINE DISEASE: Bone complications of bariatric surgery: updates on sleeve gastrectomy, fractures, and interventions.
    Eur J Endocrinol. 2020;183:R119-R132.
    PubMed     Abstract available


  13. POITOU C, Mosbah H, Clement K
    MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.
    Eur J Endocrinol. 2020;183:R149-R166.
    PubMed     Abstract available


    October 2020
  14. MARLATT KL, Lovre D, Beyl RA, Tate CR, et al
    Effect of conjugated estrogens and bazedoxifene on glucose, energy and lipid metabolism in obese postmenopausal women.
    Eur J Endocrinol. 2020;183:439-452.
    PubMed     Abstract available


    September 2020
  15. VAN DER VALK ES, van der Voorn B, Iyer AM, van den Berg S, et al
    In adults with obesity, copeptin is linked with BMI but is not associated with long-term exposure to cortisol and cortisone.
    Eur J Endocrinol. 2020 Sep 1. pii: EJE-20-0077.R1. doi: 10.1530/EJE-20-0077.
    PubMed     Abstract available


    August 2020
  16. SALERNO M, Improda N, Capalbo D
    MANAGEMENT OF ENDOCRINE DISEASE Subclinical hypothyroidism in children.
    Eur J Endocrinol. 2020;183:R13-R28.
    PubMed     Abstract available


    July 2020
  17. OBERG E, Lundell C, Blomberg L, Gidlof SB, et al
    Psychological well-being and personality in relation to weight loss following behavioral modification intervention in obese women with polycystic ovary syndrome: a randomized controlled trial.
    Eur J Endocrinol. 2020;183:1-11.
    PubMed     Abstract available


  18. FORTUIN-DE SMIDT MC, Mendham AE, Hauksson J, Hakim O, et al
    Effect of exercise training on insulin sensitivity, hyperinsulinemia and ectopic fat in black South African women: a randomized controlled trial.
    Eur J Endocrinol. 2020;183:51-61.
    PubMed     Abstract available


  19. CLARKE BM, Vincent AD, Martin S, Adams R, et al
    Obstructive sleep apnea is not an independent determinant of testosterone in men.
    Eur J Endocrinol. 2020;183:31-39.
    PubMed     Abstract available


  20. ROTTOLI M, Bernante P, Belvedere A, Balsamo F, et al
    How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0541.R2. doi: 10.1530/EJE-20-0541.
    PubMed     Abstract available


  21. RADETTI G, Fanolla A, Lupi F, Sartorio A, et al
    BMI as criterion to start the work up in obesity.
    Eur J Endocrinol. 2020 Jul 1. pii: EJE-20-0640.R1. doi: 10.1530/EJE-20-0640.
    PubMed     Abstract available


    June 2020
  22. DEAL CL, Rogol AD
    Growth hormone treatments and cognitive functioning in children with Prader-Willi syndrome.
    Eur J Endocrinol. 2020;182:C21-C25.
    PubMed    


    May 2020
  23. MEZZULLO M, Di Dalmazi G, Fazzini A, Baccini M, et al
    Impact of age, body weight and metabolic risk factors on steroid reference intervals in men.
    Eur J Endocrinol. 2020;182:459-471.
    PubMed     Abstract available


  24. SPRUNG VS, Bowden Davies KA, Norman JA, Thompson A, et al
    Metabolic syndrome is associated with reduced flow mediated dilation independent of obesity status.
    Eur J Endocrinol. 2020 May 1. pii: EJE-20-0098.R1. doi: 10.1530/EJE-20-0098.
    PubMed     Abstract available


    April 2020
  25. LI G, Li Y, Han L, Wang D, et al
    Interaction between early environment and genetic predisposition instigates the metabolically obese, normal weight phenotype in children: findings from the BCAMS study.
    Eur J Endocrinol. 2020;182:393-403.
    PubMed     Abstract available


  26. DONZE SH, Damen L, Mahabier EF, Hokken-Koelega ACS, et al
    Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
    Eur J Endocrinol. 2020;182:405-411.
    PubMed     Abstract available


    March 2020
  27. HANSEN S, Jorgensen NR, Hermann AP, Stoving RK, et al
    Continuous decline in bone mineral density and deterioration of bone microarchitecture 7 years after Roux-en-Y gastric bypass surgery.
    Eur J Endocrinol. 2020;182:303-311.
    PubMed     Abstract available


    February 2020
  28. WILDING JP
    Endocrine testing in obesity.
    Eur J Endocrinol. 2020 Feb 1. pii: EJE-20-0099. doi: 10.1530/EJE-20-0099.
    PubMed     Abstract available


  29. SHEN Z, Cen L, Chen X, Pan J, et al
    Increased risk of low bone mineral density in patients with non-alcoholic fatty liver disease: a cohort study.
    Eur J Endocrinol. 2020;182:157-164.
    PubMed     Abstract available


    January 2020
  30. PASQUALI R, Casanueva F, Haluzik M, van Hulsteijn L, et al
    European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.
    Eur J Endocrinol. 2020;182:G1-G32.
    PubMed     Abstract available


  31. BELLO O, Ladwa M, Hakim O, Marathe C, et al
    Differences in the link between insulin sensitivity and ectopic fat in men of Black African and White European ethnicity.
    Eur J Endocrinol. 2020;182:91-101.
    PubMed     Abstract available


  32. VAN HULSTEIJN LT, Pasquali R, Casanueva F, Haluzik M, et al
    Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis.
    Eur J Endocrinol. 2020;182:11-21.
    PubMed     Abstract available


    December 2019
  33. RICOTTI R, Solito A, Mariotti Zani E, Caputo M, et al
    THE RELATIONSHIP BETWEEN CORTISOL AND IGF-I INFLUENCES METABOLIC ALTERATION IN PEDIATRIC OVERWEIGHT AND OBESITY.
    Eur J Endocrinol. 2019 Dec 1. pii: EJE-19-0792.R1. doi: 10.1530/EJE-19-0792.
    PubMed     Abstract available


    November 2019
  34. FITTIPALDI A, Hernandez J, Castrogiovanni D, Lufrano D, et al
    PLASMA LEVELS OF GHRELIN, DES-ACYL GHRELIN AND LEAP2 IN CHILDREN WITH OBESITY: CORRELATION WITH AGE AND INSULIN RESISTANCE.
    Eur J Endocrinol. 2019 Nov 1. pii: EJE-19-0684.R2. doi: 10.1530/EJE-19-0684.
    PubMed     Abstract available


  35. RAZNY U, Polus A, Goralska J, Zdzienicka A, et al
    Effect of insulin resistance on whole blood mRNA and microRNA expression affecting bone turnover.
    Eur J Endocrinol. 2019;181:525-537.
    PubMed     Abstract available


    September 2019
  36. KO SH, Han K, Yun JS, Chung S, et al
    Impact of obesity and diabetes on the incidence of kidney and bladder cancers: a nationwide cohort study.
    Eur J Endocrinol. 2019 Sep 1. pii: EJE-19-0500.R2. doi: 10.1530/EJE-19-0500.
    PubMed     Abstract available


    August 2019
  37. CORICA D, Zusi C, Olivieri F, Marigliano M, et al
    Vitamin D affects insulin sensitivity and beta-cell function in obese non-diabetic youths.
    Eur J Endocrinol. 2019 Aug 1. pii: EJE-19-0369.R1. doi: 10.1530/EJE-19-0369.
    PubMed     Abstract available


    June 2019
  38. OTTEN J, Ryberg M, Mellberg C, Andersson T, et al
    Postprandial levels of GLP-1, GIP and glucagon after 2 years of weight loss with a Paleolithic diet: a randomised controlled trial in healthy obese women.
    Eur J Endocrinol. 2019;180:417-427.
    PubMed     Abstract available


    April 2019
  39. KUMARENDRAN B, Sumilo D, O'Reilly MW, Toulis KA, et al
    Increased risk of obstructive sleep apnoea in women with polycystic ovary syndrome: a population-based cohort study.
    Eur J Endocrinol. 2019;180:265-272.
    PubMed     Abstract available


    February 2019
  40. PAPATHANASIOU AE, Nolen-Doerr E, Farr OM, Mantzoros CS, et al
    GEOFFREY HARRIS PRIZE LECTURE 2018: Novel pathways regulating neuroendocrine function, energy homeostasis and metabolism in humans.
    Eur J Endocrinol. 2019;180:R59-R71.
    PubMed     Abstract available


    December 2018
  41. XU Y, Li H, Wang A, Su Z, et al
    Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study.
    Eur J Endocrinol. 2018;179:343-352.
    PubMed     Abstract available


    October 2018
  42. RHARASS T, Lucas S
    MECHANISMS IN ENDOCRINOLOGY: Bone marrow adiposity and bone, a bad romance?
    Eur J Endocrinol. 2018;179:R165-R182.
    PubMed     Abstract available


    August 2018
  43. BILLETER AT, de la Garza Herrera JR, Scheurlen KM, Nickel F, et al
    MANAGEMENT OF ENDOCRINE DISEASE: Which metabolic procedure? Comparing outcomes in sleeve gastrectomy and Roux-en Y gastric bypass.
    Eur J Endocrinol. 2018;179:R77-R93.
    PubMed     Abstract available


    July 2018
  44. RHARASS T, Lucas S
    MECHANISMS IN ENDOCRINOLOGY: Bone Marrow Adiposity and bone, a bad romance?
    Eur J Endocrinol. 2018 Jul 4. pii: EJE-18-0182. doi: 10.1530/EJE-18-0182.
    PubMed     Abstract available


  45. MENDOZA LC, Harreiter J, Simmons D, Desoye G, et al
    Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point.
    Eur J Endocrinol. 2018;179:39-49.
    PubMed     Abstract available


  46. JORGENSEN JOL, Juul A
    THERAPY OF ENDOCRINE DISEASE: Growth hormone replacement therapy in adults: 30 years of personal clinical experience.
    Eur J Endocrinol. 2018;179:R47-R56.
    PubMed     Abstract available


  47. SALAMUN V, Jensterle M, Janez A, Vrtacnik Bokal E, et al
    Liraglutide increases IVF pregnancy rates in obese PCOS women with poor response to first-line reproductive treatments: a pilot randomized study.
    Eur J Endocrinol. 2018;179:1-11.
    PubMed     Abstract available


    June 2018
  48. ANDERSEN MS, Glintborg D
    Diagnosis and follow-up of type 2 diabetes in women with PCOS. A role of OGTT?
    Eur J Endocrinol. 2018 Jun 19. pii: EJE-18-0237. doi: 10.1530/EJE-18-0237.
    PubMed     Abstract available


    March 2018
  49. BELLO-CHAVOLLA OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, et al
    METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes.
    Eur J Endocrinol. 2018 Mar 13. pii: EJE-17-0883. doi: 10.1530/EJE-17-0883.
    PubMed     Abstract available


    January 2018
  50. BONOMI M, Vezzoli V, Krausz C, Guizzardi F, et al
    Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH).
    Eur J Endocrinol. 2018;178:23-32.
    PubMed     Abstract available


  51. GUO Y, Huang ZP, Liu CQ, Qi L, et al
    Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery.
    Eur J Endocrinol. 2018;178:43-56.
    PubMed     Abstract available


    December 2017
  52. THARAKAN G, Behary P, Wewer Albrechtsen NJ, Chahal H, et al
    Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Eur J Endocrinol. 2017;177:455-464.
    PubMed     Abstract available


    September 2017
  53. SCHIFFER L, Kempegowda P, Arlt W, O'Reilly MW, et al
    MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease.
    Eur J Endocrinol. 2017;177:R125-R143.
    PubMed     Abstract available


    July 2017
  54. MORELLI V, Palmieri S, Lania A, Tresoldi A, et al
    Cardiovascular events in patients with mild autonomous cortisol secretion: analysis with artificial neural networks.
    Eur J Endocrinol. 2017;177:73-83.
    PubMed     Abstract available


    June 2017
  55. SHANBHOGUE VV, Stoving RK, Frederiksen KH, Hanson S, et al
    Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study.
    Eur J Endocrinol. 2017;176:685-693.
    PubMed     Abstract available


  56. ALBUQUERQUE EV, Scalco RC, Jorge AA
    MANAGEMENT OF ENDOCRINE DISEASE: Diagnostic and therapeutic approach of tall stature.
    Eur J Endocrinol. 2017;176:R339-R353.
    PubMed     Abstract available


  57. WIJNEN M, van den Heuvel-Eibrink MM, Janssen JAMJL, Catsman-Berrevoets CE, et al
    Very long-term sequelae of craniopharyngioma.
    Eur J Endocrinol. 2017;176:755-767.
    PubMed     Abstract available


  58. SIMON V, Cota D
    MECHANISMS IN ENDOCRINOLOGY: Endocannabinoids and metabolism: past, present and future.
    Eur J Endocrinol. 2017;176:R309-R324.
    PubMed     Abstract available


    May 2017
  59. HAMER M, Johnson W, Bell JA
    Improving risk estimates for metabolically healthy obesity and mortality using a refined healthy reference group.
    Eur J Endocrinol. 2017 May 31. pii: EJE-17-0217. doi: 10.1530/EJE-17-0217.
    PubMed     Abstract available


    April 2017
  60. BEAMISH AJ, Reinehr T
    Should bariatric surgery be performed in adolescents?
    Eur J Endocrinol. 2017;176:D1-D15.
    PubMed     Abstract available


  61. CHEMAITILLY W, Cohen LE
    DIAGNOSIS OF ENDOCRINE DISEASE: Endocrine late-effects of childhood cancer and its treatments.
    Eur J Endocrinol. 2017;176:R183-R203.
    PubMed     Abstract available


    February 2017
  62. LOPEZ M
    EJE PRIZE 2017: Hypothalamic AMPK: a golden target against obesity?
    Eur J Endocrinol. 2017 Feb 23. pii: EJE-16-0927. doi: 10.1530/EJE-16-0927.
    PubMed     Abstract available


    January 2017
  63. GRASA MD, Gulfo J, Camps N, Alcala R, et al
    Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity.
    Eur J Endocrinol. 2017 Jan 11. pii: EJE-16-0834. doi: 10.1530/EJE-16-0834.
    PubMed     Abstract available


    December 2016
  64. SCHERNTHANER-REITER MH, Kasses D, Tugendsam C, Riedl M, et al
    Growth differentiation factor 15 increases following oral glucose ingestion: effect of meal composition and obesity.
    Eur J Endocrinol. 2016;175:623-631.
    PubMed     Abstract available


  65. GUDE MF, Hjortebjerg R, Oxvig C, Thyo AA, et al
    PAPP-A, IGFBP-4 and IGF-II are secreted by human adipose tissue cultures in a depot-specific manner.
    Eur J Endocrinol. 2016;175:509-519.
    PubMed     Abstract available


    October 2016
  66. DE ARAUJO IM, Salmon CE, Nahas AK, Nogueira-Barbosa MH, et al
    Marrow Adipose Tissue Spectrum in Obesity and Type 2 Diabetes Mellitus.
    Eur J Endocrinol. 2016 Oct 5. pii: EJE-16-0448.
    PubMed     Abstract available


    September 2016
  67. ARAUJO EP, Moraes JC, Cintra DE, Velloso LA, et al
    MECHANISMS IN ENDOCRINOLOGY: Hypothalamic inflammation and nutrition.
    Eur J Endocrinol. 2016;175:R97-R105.
    PubMed     Abstract available


    July 2016
  68. THUZAR M, Ho KK
    MECHANISMS IN ENDOCRINOLOGY: Brown adipose tissue in humans: regulation and metabolic significance.
    Eur J Endocrinol. 2016;175:R11-25.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obesity is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: